Temporary Phone Service Interruption – Friday Evening. We will be upgrading our phone system Friday beginning at 5:30 PM. After-hours calls in the early part of the evening may not connect until service is restored later that night. For medical emergencies, please call 9-1-1. Thank you for your patience and understanding.
The alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression. Check for active clinical trials using this agent. (NCI Thesaurus)